Magazine Article | January 3, 2023

Peter Marks: Prioritizing Better Communication And Faster Product Reviews

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the FDA since 2016, is an animated speaker exuding an obvious enthusiasm for the job he holds as chief regulator of three key product areas: vaccines, cell and gene therapies, and blood-related products. Marks was instrumental in the establishment and success of Operation Warp Speed’s COVID-19 vaccine development and scale-up assistance, and remains focused on what he says is the FDA and drug industry’s shared mission: to work as quickly as possible to get patients new drugs and medical advances proven to alleviate their suffering.

VIEW THE MAGAZINE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader